glp-1 multiple endocrine neoplasia Research Reveals Potential Risks of Popular Medications for Some with Neuroendocrine Cancer Targeting GLP-1, GIP & GCG

Insurance navigation support may be available

Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts

Senior administration officials told reporters that the deals with Eli Lilly and Novo Nordisk follow the contours of the other most favored nation drug pricing deals announced earlier this year with Pfizer and AstraZeneca

doi: 10.1080/00325481.2021.2002616

Loss of biofilm formation in an emerging foodborne pathogen EAEC under acid stress

The impact of GLP-1 RAs on mortality, MACEs, and MAKEs The crude incidence of mortality rate was 22.91 per 1000 person-years, which was significantly lower in the GLP-1 RAs users group than in the non-users group (6.8% vs